Biosimilar Secondary Antibodies
Biosimilar Secondary Antibodies
Secondary antibodies where biosimilar human is the host species. Secondary antibodies must be raised against the host species of the primary antibody. Includes different antigens, classifications, conjugations, and isotypes.
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
1
–
15
of
29
results
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions and unreacted dye was removed. |
---|---|
Target Species | Human |
Conjugate | Alexa Fluor 647 |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Antigen | HER2 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | CD340; ERBB2; HER-2; HER-2/neu; HER2; NEU; proto-oncogene c-ErbB-2 |
Gene ID (Entrez) | 2064 |
Formulation | Aqueous buffered solution containing BSA and ≤0.09% sodium azide. |
Immunogen | A431 Cell Line Expressing EGFR |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | Trastuzumab297.rMAb (also known as Trastuzumab N297A Biosimilar.rMAb) |
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD20 Rituximab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | B1; Bp35; LEU-16; MS4A1 |
Gene ID (Entrez) | 931 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | Human CD20 |
Primary or Secondary | Primary |
Clone | Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) |
CD20 Rituximab297 anti-Human, RY586, Clone: Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb), BD OptiBuild™
Biosimilar Monoclonal Antibody
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Conjugate | RY586 |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD20 Rituximab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | B1; Bp35; LEU-16; MS4A1 |
Gene ID (Entrez) | 931 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | Human CD20 |
Primary or Secondary | Primary |
Clone | Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) |
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD20 Rituximab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | B1; Bp35; LEU-16; MS4A1 |
Gene ID (Entrez) | 931 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | Human CD20 |
Primary or Secondary | Primary |
Clone | Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) |
CD20 Rituximab297 anti-Human, BV650, Clone: Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb), BD OptiBuild™
Biosimilar Monoclonal Antibody
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD20 Rituximab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | B1; Bp35; LEU-16; MS4A1 |
Gene ID (Entrez) | 931 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | Human CD20 |
Primary or Secondary | Primary |
Clone | Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) |
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | HER2 Trastuzumab297.rMAb |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | CD340; ERBB2; HER-2; HER-2/neu; HER2; NEU; proto-oncogene c-ErbB-2 |
Gene ID (Entrez) | 2064 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | A431 Cell Line Expressing EGFR |
Primary or Secondary | Primary |
Clone | Trastuzumab297.rMAb (also known as Trastuzumab N297A Biosimilar.rMAb) |
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | HER2 Trastuzumab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | CD340; ERBB2; HER-2; HER-2/neu; HER2; NEU; proto-oncogene c-ErbB-2 |
Gene ID (Entrez) | 2064 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | A431 Cell Line Expressing EGFR |
Primary or Secondary | Primary |
Clone | Trastuzumab297.rMAb (also known as Trastuzumab N297A Biosimilar.rMAb) |
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | HER2 Trastuzumab297.rMAb |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | CD340; ERBB2; HER-2; HER-2/neu; HER2; NEU; proto-oncogene c-ErbB-2 |
Gene ID (Entrez) | 2064 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | A431 Cell Line Expressing EGFR |
Primary or Secondary | Primary |
Clone | Trastuzumab297.rMAb (also known as Trastuzumab N297A Biosimilar.rMAb) |
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | HER2 Trastuzumab297.rMAb |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | CD340; ERBB2; HER-2; HER-2/neu; HER2; NEU; proto-oncogene c-ErbB-2 |
Gene ID (Entrez) | 2064 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | A431 Cell Line Expressing EGFR |
Primary or Secondary | Primary |
Clone | Trastuzumab297.rMAb (also known as Trastuzumab N297A Biosimilar.rMAb) |
CD20 Rituximab297 anti-Human, BV786, Clone: Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb), BD OptiBuild™
Biosimilar Monoclonal Antibody
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD20 Rituximab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | B1; Bp35; LEU-16; MS4A1 |
Gene ID (Entrez) | 931 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | Human CD20 |
Primary or Secondary | Primary |
Clone | Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) |
CD20 Rituximab297 anti-Human, BV510, Clone: Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb), BD OptiBuild™
Biosimilar Monoclonal Antibody
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD20 Rituximab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | B1; Bp35; LEU-16; MS4A1 |
Gene ID (Entrez) | 931 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | Human CD20 |
Primary or Secondary | Primary |
Clone | Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) |
CD20 Rituximab297 anti-Human, RB545, Clone: Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb), BD OptiBuild™
Biosimilar Monoclonal Antibody
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Conjugate | RB545 |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD20 Rituximab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | B1; Bp35; LEU-16; MS4A1 |
Gene ID (Entrez) | 931 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | Human CD20 |
Primary or Secondary | Primary |
Clone | Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) |
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Conjugate | RB780 |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | HER2 Trastuzumab297.rMAb |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | CD340; ERBB2; HER-2; HER-2/neu; HER2; NEU; proto-oncogene c-ErbB-2 |
Gene ID (Entrez) | 2064 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | A431 Cell Line Expressing EGFR |
Primary or Secondary | Primary |
Clone | Trastuzumab297.rMAb (also known as Trastuzumab N297A Biosimilar.rMAb) |
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | HER2 Trastuzumab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | CD340; ERBB2; HER-2; HER-2/neu; HER2; NEU; proto-oncogene c-ErbB-2 |
Gene ID (Entrez) | 2064 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | A431 Cell Line Expressing EGFR |
Primary or Secondary | Primary |
Clone | Trastuzumab297.rMAb (also known as Trastuzumab N297A Biosimilar.rMAb) |
CD20 Rituximab297 anti-Human, BV605, Clone: Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb), BD OptiBuild™
Biosimilar Monoclonal Antibody
Content And Storage | Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. |
---|---|
Target Species | Human |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD20 Rituximab297 |
Regulatory Status | RUO |
Purification Method | Affinity Chromatography |
Gene Alias | B1; Bp35; LEU-16; MS4A1 |
Gene ID (Entrez) | 931 |
Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
Classification | Monoclonal |
Immunogen | Human CD20 |
Primary or Secondary | Primary |
Clone | Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) |